Skip to main content

Table 1

From: O415 Efficacy and safety of 48-week maintenance with QD ATV vs ATV/r (both + 2NRTIs) in patients with VL <50 c/mL after induction with ATV/r + 2NRTIs: study AI424136

Proportion of pts with HIV RNA <50/400 c/mL through Wk 48 of MP (ITT)

ATV/r (N = 85)

ATV (N = 87)

Difference Estimate (95%CI) (ATV – ATV/r)

% <50 c/mL

75

78

2.9 (69.8, 15.5)

% <400 c/mL

81

86